Pure Global
NCT05788575

Study of the Incidence of Surgical Site Infections Developed by Patients Hospitalized in the Wards of a Large Teaching Hospital in Rome, Italy

Study of the Incidence of Surgical Site Infections (SSI) in a Large Teaching Hospital in Rome, Italy.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS·ClinicalTrials.gov·procedureCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Surgical Site Infection
Drug/Device/Intervention
surgery
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Location
Rome, Italy
Timeline & enrollment
Phase
N/A
Start date
Jul 02, 2018
End date
Nov 15, 2022
Enrollment
5424 participants
Primary outcome

Incidence of surgical site infection

Summary

The surgical departments of the hospital were included in the study on a rotational basis
 over a period of 5 months. All patients undergoing surgery during this period were enrolled
 in the study.
 
 The data collection in each department lasted 6 months (8 in the case of the use of
 prostheses) of which:
 
 - 5 months of continuous survey of hospitalized patients
 
 - 30 days of post-operative surveillance for all operations, 90 days for operations
 involving the use of prosthetic material Surveillance ends when a surgical site
 infection occurs, even if the event is prior to 30 or 90 days.
 
 For each surgery, information was recorded such as the type of surgery, duration, ASA score,
 prophylaxis.

ICD-10 classifications
Infection following a procedure, not elsewhere classifiedBacterial infection of unspecified siteOther bacterial infections of unspecified siteInfection of obstetric surgical woundOther specified local infections of skin and subcutaneous tissue
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05788575
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05788575 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS and is currently Completed. The study focuses on Surgical Site Infection. Target enrollment is 5424 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.